Radiation for slow-growing lymphoma in the eye
Part of Cancer, Eyes & vision clinical trials.
This trial tests a short course of low-dose radiation (12 Gy in 6 sessions) to treat slow-growing lymphoma in the eye area. It aims to control the lymphoma while minimizing side effects.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have a slow-growing (indolent) type of non-Hodgkin lymphoma that affects one or both eyes.
- You have not had radiation therapy to the eye area before.
- You are not pregnant.
- You are generally able to take care of yourself (with or without some help).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a combination of a targeted drug (Orelabrutinib) and radiation therapy for adults newly diagnosed with a slow-growing lymphoma around the eye. The goal is to see if this approach works well and is safe for people who have not had treatment before.
This trial compares two treatments for a slow-growing eye lymphoma called MALT lymphoma: a targeted injection (rituximab) directly into the tumor versus low-dose radiation. The goal is to see which is safer and works better, while avoiding whole-body side effects.
This trial tests whether giving a lower dose of radiation than usual works well for people with slow-growing B-cell lymphomas. It aims to reduce side effects while still controlling the disease.
This study compares two treatments for a type of lymphoma in the eye area: injecting a drug called rituximab directly into the tumor versus using targeted radiation therapy. The goal is to see which treatment works better with fewer side effects.
This trial tests a combination of radiation therapy to specific tumor sites followed by a bispecific antibody (a type of immunotherapy that targets cancer cells). It's designed for people with diffuse large B-cell lymphoma that has not responded to or has come back after at least two prior treatments.
This trial tests whether a lower dose of radiation, guided by PET scans, is safe and effective for people with early-stage but unfavorable Hodgkin lymphoma. It aims to reduce side effects while keeping the treatment strong.
Hear when a new Orbital Lymphoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.